Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, August 29 2016 12:41am ET - U.S. Markets open in 8 hours and 49 minutes.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drugs - Generic News
Latest News
Sunday, Aug 28, 2016
·Allergan: An Undervalued Powerhouse
- 1 hour, 39 minutes ago
·Pharma Companies Are Spending Millions To Sustain High Drug Prices
- Sun 11:20 am ET
Saturday, Aug 27, 2016
·[$$] Time to Sell Mylan
at Barrons.com - Sat 12:01 am ET
·What it’s like to have life-threatening allergies and be unable to afford the EpiPen
at MarketWatch - Fri 6:59 pm ET
Friday, Aug 26, 2016
·Sophiris Bio Closes Underwritten Public Offering
PR Newswire - Fri Aug 26
·Black Rock Pharmacy Co-Owner Arthur To CNBC: 'There's a Huge Issue With PBMs'
at TheStreet.com - Fri Aug 26
·4-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Lipocine Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
- Fri Aug 26
·FTC Details Concerns on Generic Drug Company Mergers
at TheStreet.com - Fri Aug 26
·Selling Pressure Continues For Mylan
- Fri Aug 26
·FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lipocine, Inc. (LPCN) & Lead Plaintiff Deadline August 30, 2016
- Fri Aug 26
·Weekend roundup: The surprising way a smartphone can improve your child’s grades | Sizzling emerging markets | How to panic and lose money
at MarketWatch - Fri Aug 26
·Health care still has potential, analysts say
at CNBC - Fri Aug 26
·Mylan offers price plan to help patients but its programs are still short on details
at MarketWatch - Fri Aug 26
·[$$] Mylan's EpiPen Fallout Benefits Adamis
at Barrons.com - Fri Aug 26
·Trader's Daily Notebook: Is It Worth Trying to Catch a Bottom in Biotechs?
at TheStreet.com - Fri Aug 26
·Mylan's EpiPen Price Increases Highlight Its Grip on the Market
at The Wall Street Journal Online - Fri Aug 26
·PRESS DIGEST- New York Times business news - Aug 26
Reuters - Fri Aug 26
·Cramer: Mylan's EpiPen represents a big glitch in the system
at CNBC - Thu Aug 25
·Cramer: Getting to the Heart -- or the Lack of It -- of the EpiPen Issue
at TheStreet.com - Thu Aug 25
·Mylan Boosts Price Assistance for EpiPen Amid Backlash
at The Wall Street Journal Online - Thu Aug 25
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?